NASDAQ:KIDS - Orthopediatrics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$30.26 +0.17 (+0.56 %)
(As of 08/21/2018 04:00 PM ET)
Previous Close$30.09
Today's Range$29.26 - $31.15
52-Week Range$14.00 - $31.80
Volume61,800 shs
Average Volume63,571 shs
Market Capitalization$390.87 million
P/E Ratio-5.31
Dividend YieldN/A
BetaN/A
Orthopediatrics logoOrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Debt-to-Equity Ratio0.60
Current Ratio5.98
Quick Ratio3.61

Price-To-Earnings

Trailing P/E Ratio-5.31
Forward P/E Ratio-36.90
P/E GrowthN/A

Sales & Book Value

Annual Sales$45.62 million
Price / Sales8.48
Cash FlowN/A
Price / CashN/A
Book Value$3.74 per share
Price / Book8.09

Profitability

EPS (Most Recent Fiscal Year)($5.70)
Net Income$-8,930,000.00
Net Margins-61.99%
Return on Equity-192.23%
Return on Assets-42.15%

Miscellaneous

Employees69
Outstanding Shares12,790,000
Market Cap$390.87 million

Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) issued its quarterly earnings data on Thursday, August, 9th. The company reported ($0.21) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.07. The company earned $15.10 million during the quarter, compared to the consensus estimate of $14.27 million. Orthopediatrics had a negative net margin of 61.99% and a negative return on equity of 192.23%. Orthopediatrics's revenue for the quarter was up 28.0% on a year-over-year basis. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for Orthopediatrics.

What price target have analysts set for KIDS?

4 brokers have issued 12-month price targets for Orthopediatrics' stock. Their predictions range from $23.00 to $30.00. On average, they expect Orthopediatrics' share price to reach $25.6667 in the next year. This suggests that the stock has a possible downside of 15.2%. View Analyst Price Targets for Orthopediatrics.

What is the consensus analysts' recommendation for Orthopediatrics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

Who are some of Orthopediatrics' key competitors?

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 67)
  • Mr. Fred L. Hite, CFO & Director (Age 50)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 48)
  • Mr. David R. Bailey, Exec. VP (Age 39)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 48)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Has Orthopediatrics been receiving favorable news coverage?

Headlines about KIDS stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Orthopediatrics earned a news and rumor sentiment score of 0.13 on Accern's scale. They also assigned news stories about the company an impact score of 46.23 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Orthopediatrics.

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Novo Holdings A S (5.11%), Wasatch Advisors Inc. (3.14%), BlackRock Inc. (2.67%), Waddell & Reed Financial Inc. (1.79%), Royce & Associates LP (1.43%) and Cortina Asset Management LLC (1.21%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite and Harold Ruf. View Institutional Ownership Trends for Orthopediatrics.

Which institutional investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Cortina Asset Management LLC, Monarch Partners Asset Management LLC and Spark Investment Management LLC. Company insiders that have sold Orthopediatrics company stock in the last year include Daniel J Gerritzen, David R Bailey and Fred Hite. View Insider Buying and Selling for Orthopediatrics.

Which institutional investors are buying Orthopediatrics stock?

KIDS stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., BlackRock Inc., Royce & Associates LP, Kornitzer Capital Management Inc. KS, EAM Investors LLC, Novo Holdings A S, GSA Capital Partners LLP and Bank of New York Mellon Corp. Company insiders that have bought Orthopediatrics stock in the last two years include David R Pelizzon and Harold Ruf. View Insider Buying and Selling for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $30.26.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $390.87 million and generates $45.62 million in revenue each year. The company earns $-8,930,000.00 in net income (profit) each year or ($5.70) on an earnings per share basis. Orthopediatrics employs 69 workers across the globe.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  219
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel